These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36282706)

  • 1. A Scalable, Cell-based Method for the Functional Assessment of Ube3a Variants.
    Stelzer JA; Yi JJ
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36282706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.
    Yi JJ; Berrios J; Newbern JM; Snider WD; Philpot BD; Hahn KM; Zylka MJ
    Cell; 2015 Aug; 162(4):795-807. PubMed ID: 26255772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
    Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.
    Yi JJ; Paranjape SR; Walker MP; Choudhury R; Wolter JM; Fragola G; Emanuele MJ; Major MB; Zylka MJ
    J Biol Chem; 2017 Jul; 292(30):12503-12515. PubMed ID: 28559284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
    Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
    Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation Update for UBE3A variants in Angelman syndrome.
    Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
    Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angelman syndrome-associated point mutations in the Zn
    Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
    J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis.
    Weston KP; Gao X; Zhao J; Kim KS; Maloney SE; Gotoff J; Parikh S; Leu YC; Wu KP; Shinawi M; Steimel JP; Harrison JS; Yi JJ
    Nat Commun; 2021 Nov; 12(1):6809. PubMed ID: 34815418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
    Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
    Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
    LaSalle JM; Reiter LT; Chamberlain SJ
    Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analyses of the Transcriptome Reveal Ube3a-Dependent Effects on Mitochondrial-Related Pathways.
    Panov J; Simchi L; Feuermann Y; Kaphzan H
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autism-linked UBE3A gain-of-function mutation causes interneuron and behavioral phenotypes when inherited maternally or paternally in mice.
    Xing L; Simon JM; Ptacek TS; Yi JJ; Loo L; Mao H; Wolter JM; McCoy ES; Paranjape SR; Taylor-Blake B; Zylka MJ
    Cell Rep; 2023 Jul; 42(7):112706. PubMed ID: 37389991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes.
    Mabb AM; Judson MC; Zylka MJ; Philpot BD
    Trends Neurosci; 2011 Jun; 34(6):293-303. PubMed ID: 21592595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobalamins Function as Allosteric Activators of an Angelman Syndrome-Associated UBE3A/E6AP Variant.
    Müller F; Jansen J; Offensperger F; Eichbichler D; Stengel F; Scheffner M
    Chembiochem; 2024 May; 25(10):e202400184. PubMed ID: 38573110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
    Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
    Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.